{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:54:51Z","timestamp":1790877291404,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-021-01672-8","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T06:26:39Z","timestamp":1631687199000},"page":"497-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Polycystic ovary syndrome: clinical and laboratory variables related to new phenotypes using machine-learning models"],"prefix":"10.1007","volume":"45","author":[{"given":"I. S.","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. N.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. B. X.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. O.","family":"S\u00f3ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M. L.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"de C. Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Sales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Candido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. M.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6870-2063","authenticated-orcid":false,"given":"K. B.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"issue":"3","key":"1672_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cnur.2018.04.008","volume":"53","author":"R Meier","year":"2018","unstructured":"Meier R (2018) Polycystic ovary syndrome. Nurs Clin North Am 53(3):407\u2013420","journal-title":"Nurs Clin North Am"},{"issue":"2","key":"1672_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","volume":"132","author":"R Azziz","year":"2018","unstructured":"Azziz R (2018) Polycystic ovary syndrome. Obstet Gynecol 132(2):321\u2013336","journal-title":"Obstet Gynecol"},{"key":"1672_CR3","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31:2841\u20132855","journal-title":"Hum Reprod"},{"key":"1672_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S (2018) Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol 182:27\u201336","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"1672_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3904\/kjim.2009.24.4.350","volume":"24","author":"J Oh","year":"2009","unstructured":"Oh J, Lee J, Lee H, Oh Y, Sung Y, Chung H (2009) Serum C-reactive protein levels in normal-weight polycystic ovary syndrome. Korean J Intern Med 24(4):350\u2013355","journal-title":"Korean J Intern Med"},{"issue":"1","key":"1672_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/cen.12110","volume":"79","author":"N Hilali","year":"2013","unstructured":"Hilali N, Vural M, Camuzcuoglu H, Camuzcuoglu A, Nurten A (2013) Increased prolidase activity and oxidative stress in PCOS. Clin Endocrinol (Oxf) 79(1):105\u2013110","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1672_CR7","unstructured":"- National Institutes of Health (2012) Evidence-based methodology workshop on polycystic ovary syndrome. December 3\u20135. Executive summary. Final report. https:\/\/prevention.nih.gov\/docs\/programs\/pcos\/FinalReport.pdf. Accessed 22 May 2021"},{"issue":"2","key":"1672_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"W March","year":"2010","unstructured":"March W, Moore V, Willson K, Phillips D, Norman R, Davies M (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25(2):544\u2013551","journal-title":"Hum Reprod"},{"issue":"2","key":"1672_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cyto.2015.06.008","volume":"76","author":"M S\u00f3ter","year":"2015","unstructured":"S\u00f3ter M, Ferreira C, Sales M, Candido A, Reis FM, Milagres K, Ronda C, Silva I, Sousa M, Gomes K (2015) Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome. Cytokine 76(2):227\u2013235","journal-title":"Cytokine"},{"key":"1672_CR10","doi-asserted-by":"publisher","first-page":"155187","DOI":"10.1016\/j.cyto.2020.155187","volume":"134","author":"J Tosatti","year":"2020","unstructured":"Tosatti J, S\u00f3ter M, Ferreira C, Silva I, C\u00e2ndido A, Sousa M, Reis FM, Gomes K (2020) The hallmark of pro- and anti-inflammatory cytokine ratios in women with\u00a0polycystic\u00a0ovary syndrome. Cytokine 134:155187","journal-title":"Cytokine"},{"key":"1672_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mce.2017.01.017","volume":"443","author":"L Carvalho","year":"2017","unstructured":"Carvalho L, Ferreira C, S\u00f3ter M, Sales M, Rodrigues K, Martins S, Candido A, Reis FM, Silva I, Campos F, Gomes K (2017) Microparticles: inflammatory and haemostatic biomarkers in polycystic ovary syndrome. Mol Cell Endocrinol 443:155\u2013162","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"1672_CR12","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s10815-017-1030-3","volume":"34","author":"L Carvalho","year":"2017","unstructured":"Carvalho L, Ferreira C, Oliveira D, Rodrigues K, Duarte R, Teixeira M, Xavier L, Candido A, Reis F, Silva I, Campos F, Gomes K (2017) Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome. J Assist Reprod Genet 34(12):1691\u20131698","journal-title":"J Assist Reprod Genet"},{"key":"1672_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.gene.2017.11.006","volume":"644","author":"L Xavier","year":"2018","unstructured":"Xavier L, S\u00f3ter M, Sales M, Oliveira D, Reis H, Candido A, Reis FM, Silva I, Gomes K, Ferreira C (2018) Evaluation of PCSK9 levels and its genetic polymorphisms in women with polycystic ovary syndrome. Gene 644:129\u2013136","journal-title":"Gene"},{"issue":"4","key":"1672_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00404-017-4471-0","volume":"296","author":"L Carvalho","year":"2017","unstructured":"Carvalho L, Ferreira C, Candido A, Reis FM, S\u00f3ter M, Sales M, Silva I, Nunes F, Gomes K (2017) Metformin reduces total microparticles and microparticles-expressing tissue factor in women with polycystic ovary syndrome. Arch Gynecol Obstet 296(4):617\u2013621","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"1672_CR15","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3109\/09513590.2013.819086","volume":"29","author":"M Sales","year":"2013","unstructured":"Sales M, S\u00f3ter M, Candido A, Fernandes A, Oliveira F, Ferreira A, Sousa M, Ferreira C, Gomes K (2013) Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G\/5G polymorphism and metabolic\/proinflammatory factors in polycystic ovary syndrome. Gynecol Endocrinol 29(10):936\u2013939","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1672_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/09513590.2018.1512966","volume":"35","author":"L Xavier","year":"2019","unstructured":"Xavier L, Gontijo N, Rodrigues K, C\u00e2ndido A, Reis F, Sousa M, Silveira J, Oliveira F, Ferreira C, Gomes K (2019) Polymorphisms in vitamin D receptor gene, but not vitamin D levels, are associated with polycystic ovary syndrome in Brazilian women. J Gynecol Endocrinol 35(2):146\u2013149","journal-title":"J Gynecol Endocrinol"},{"issue":"3","key":"1672_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/jog.13250","volume":"43","author":"G Reis","year":"2017","unstructured":"Reis G, Gontijo N, Rodrigues K, Alves M, Ferreira C, Gomes K (2017) Vitamin D receptor polymorphisms and the polycystic ovary syndrome: a systematic review. J Obstet Gynaecol Res 43(3):436\u2013446","journal-title":"J Obstet Gynaecol Res"},{"issue":"9","key":"1672_CR18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1080\/09513590.2020.1739267","volume":"36","author":"M Alves","year":"2020","unstructured":"Alves M, de Souza I, Ferreira C, C\u00e2ndido AL, Bizzi M, OliveiraReisGomes FFK (2020) Galectin-3 is a potential biomarker to insulin resistance and obesity in women with polycystic ovary syndrome. Gynecol Endocrinol 36(9):760\u2013763","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"1672_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1530\/EJE-19-0505","volume":"181","author":"F Oliveira","year":"2019","unstructured":"Oliveira F, Mamede M, Bizzi M, Rocha A, Ferreira C, Gomes K, C\u00e2ndido AL, Reis F (2019) Brown adipose tissue activity is reduced in women with polycystic ovary syndrome. Eur J Endocrinol 181(5):473\u2013480","journal-title":"Eur J Endocrinol"},{"issue":"20","key":"1672_CR20","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","volume":"132","author":"C Rahul","year":"2015","unstructured":"Rahul C (2015) Machine learning in medicine. Circulation 132(20):1920\u20131930","journal-title":"Circulation"},{"issue":"8","key":"1672_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/01616412.2019.1609159","volume":"41","author":"H Saber","year":"2019","unstructured":"Saber H, Somai M, Rajah G, Scalzo F, Liebeskind D (2019) Predictive analytics and machine learning in stroke and neurovascular medicine. Neurol Res 41(8):681\u2013690","journal-title":"Neurol Res"},{"issue":"6","key":"1672_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/joim.12822","volume":"284","author":"G Handelman","year":"2018","unstructured":"Handelman G, Kok H, Chandra R, Razavi A, Lee M, Asadi H (2018) eDoctor: machine learning and the future of medicine. J Intern Med 284(6):603\u2013619","journal-title":"J Intern Med"},{"issue":"1","key":"1672_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L (2001) Random forests. Mach Learn 45(1):5\u201332","journal-title":"Mach Learn"},{"issue":"1","key":"1672_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"M Lundberg","year":"2020","unstructured":"Lundberg M, Erion G, Chen H, DeGrave A, Prutkin J, Nair B, Katz R, Himmelfarb J, Bansal N, Lee S (2020) From local explanations to global understanding with explainable AI for trees. Nat Mach Intell 2(1):56\u201367","journal-title":"Nat Mach Intell"},{"key":"1672_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) The Rotterdam ESHRE\/ASRM revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325","journal-title":"Fertil Steril"},{"issue":"3","key":"1672_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0066-782X2001001500001","volume":"77","author":"R Santos","year":"2001","unstructured":"Santos R (2001) III Diretrizes Brasileiras Sobre Dislipidemias e Diretriz de Preven\u00e7\u00e3o da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 77(3):1\u201325","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"1672_CR27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5582\/ddt.2015.01207","volume":"9","author":"Q Tang","year":"2015","unstructured":"Tang Q, Xueqin L, Song P, Xu L (2015) Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future. Drug Discov Ther 9(6):380\u2013385","journal-title":"Drug Discov Ther"},{"key":"1672_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.exger.2016.06.007","volume":"82","author":"F Lwow","year":"2016","unstructured":"Lwow F, Jedrzejuk D, Milewicz A, Szmigiero L (2016) Lipid accumulation product (LAP) as a criterion for the identification of the healthy obesity phenotype in postmenopausal women. Exper Gerontol 82:81\u201387","journal-title":"Exper Gerontol"},{"key":"1672_CR29","unstructured":"Keany E (2021) BorutaShap 1.0.15 2020. https:\/\/pypi.org\/project\/BorutaShap\/. Accessed 26 May 2021"},{"issue":"11","key":"1672_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i11","volume":"36","author":"M Kursa","year":"2010","unstructured":"Kursa M, Rudnicki W (2010) Feature selection with the Boruta package. J Stat Softw 36(11):1\u201313","journal-title":"J Stat Softw"},{"key":"1672_CR31","first-page":"161","volume-title":"Clustering methods: a history of k-means algorithms. Selected contributions in data analysis and classification","author":"H Bock","year":"2007","unstructured":"Bock H (2007) Clustering methods: a history of k-means algorithms. Selected contributions in data analysis and classification. Springer, Berlin, pp 161\u2013172"},{"issue":"9","key":"1672_CR32","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"H Teede","year":"2018","unstructured":"Teede H, Misso M, Costello M, Dokras A, Laven J, Moran L, Piltonen T, Norman R, International PCOS Network (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod 33(9):1602\u20131618","journal-title":"Hum Reprod"},{"issue":"2","key":"1672_CR33","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.fertnstert.2009.06.025","volume":"94","author":"M Pall","year":"2010","unstructured":"Pall M, Azziz R, Beires J, Pignatelli D (2010) The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertil Steril 94(2):684\u2013689","journal-title":"Fertil Steril"},{"issue":"4","key":"1672_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5455\/medarh.2020.74.289-293","volume":"74","author":"Z Saadia","year":"2020","unstructured":"Saadia Z (2020) Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS) obese vs non- obese women. Med Arch 74(4):289\u2013293","journal-title":"Med Arch"},{"key":"1672_CR35","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1006\/mgme.2000.3036","volume":"71","author":"P Speiser","year":"2000","unstructured":"Speiser P, Knochenhauer E, Dewailly D, Fruzzetti F, Marcondes J, Azziz R (2000) A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype. Mol Genet Metab 71:527\u2013534","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1672_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1001-9294(15)30008-0","volume":"30","author":"L Qiu","year":"2015","unstructured":"Qiu L, Liu J, Hei Q (2015) Association between two polymorphisms of follicle stimulating hormone receptor gene and susceptibility to polycystic ovary syndrome: a meta-analysis. Chin Med Sci J 30(1):44\u201350","journal-title":"Chin Med Sci J"},{"issue":"2","key":"1672_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/01443615.2020.1758926","volume":"41","author":"R Deniz","year":"2021","unstructured":"Deniz R, Yavuzkir S, Ugur K, Ustebay D, Baykus Y, Ustebay S, Aydin S (2021) Subfatin and asprosin, two new metabolic players of polycystic ovary syndrome. J Obstet Gynaecol 41(2):279\u2013284","journal-title":"J Obstet Gynaecol"},{"key":"1672_CR38","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/humrep\/deu133","volume":"29","author":"D Glintborg","year":"2014","unstructured":"Glintborg D, Altinok M, Mumm H, Buch K, Ravn P, Andersen M (2014) Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome. Hum Reprod 29:1773\u20131779","journal-title":"Hum Reprod"},{"key":"1672_CR39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fendo.2020.00263","volume":"11","author":"H Yang","year":"2020","unstructured":"Yang H, Di J, Pan J, Yu R, Teng Y, Cai Z, Deng X (2020) The Association between prolactin and metabolic parameters in pcos women: a retrospective analysis. Front Endocrinol (Lausanne) 11:263","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1672_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/jsm.12327","volume":"11","author":"G Corona","year":"2014","unstructured":"Corona G, Wu F, Rastrelli G, Lee D, Forti G, O\u2019Connor D, O\u2019Neill T, Pendleton N, Bartfai G, Boonen S, Casanueva F, Finn J, Huhtaniemi I, Kula K, Punab M, Vanderschueren D, Rutter M, Maggi M, EMAS Study Group (2014) Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European male aging study (EMAS). J Sex Med 11(1):240\u2013253","journal-title":"J Sex Med"},{"issue":"1","key":"1672_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00592-013-0493-7","volume":"51","author":"R Wagner","year":"2014","unstructured":"Wagner R, Heni M, Linder K, Ketterer C, Peter A, Bohm A, Hatziagelaki E, Stefan N, Staiger H, H\u00e4ring H, Fritsche A (2014) Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans. Acta Diabetol 51(1):71\u201378","journal-title":"Acta Diabetol"},{"issue":"1","key":"1672_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41\u201347","journal-title":"Hum Reprod"},{"key":"1672_CR43","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1055\/s-0031-1277136","volume":"119","author":"S Cupisti","year":"2011","unstructured":"Cupisti S, Haeberle L, Schell C, Richter H, Schulze C, Hildebrandt T, Oppelt P, Beckmann M, Dittrich R, Mueller A (2011) The different phenotypes of polycystic ovary syndrome: no advantages for identifying women with aggravated insulin resistance or impaired lipids. Exp Clin Endocrinol Diabetes 119:502\u2013508","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1672_CR44","first-page":"763","volume":"16","author":"F Mehrabian","year":"2011","unstructured":"Mehrabian F, Khani B, Kelishadi R, Kermani N (2011) The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females. J Res Med Sci 16:763\u2013769","journal-title":"J Res Med Sci"},{"key":"1672_CR45","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.fertnstert.2007.01.032","volume":"88","author":"R Shroff","year":"2007","unstructured":"Shroff R, Syrop C, Davis W, Van Voorhis B, Dokras A (2007) Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril 88:1389\u20131395","journal-title":"Fertil Steril"},{"issue":"1","key":"1672_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R (2016) Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106(1):6\u201315","journal-title":"Fertil Steril"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01672-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-021-01672-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01672-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T14:32:05Z","timestamp":1675693925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-021-01672-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["1672"],"URL":"https:\/\/doi.org\/10.1007\/s40618-021-01672-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"9 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest or financial\/personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee (COEP) of the Federal University of Minas Gerais (UFMG) approved the study (CAAE 0379.0.203.000-11).  We certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}